Assuntos
Anti-Hipertensivos/uso terapêutico , Hipertensão/epidemiologia , Transplante de Rim/fisiologia , Ácido Micofenólico/uso terapêutico , Adolescente , Azatioprina/uso terapêutico , Criança , Ciclosporina/uso terapêutico , Rejeição de Enxerto/prevenção & controle , Humanos , Terapia de Imunossupressão/métodos , Transplante de Rim/imunologia , Morbidade , Ácido Micofenólico/análogos & derivados , Prevalência , Recidiva , Estudos RetrospectivosRESUMO
BACKGROUND: Acute rejection episodes (ARE) of kidney transplants are considered as risk factor in the development of chronic rejection. In adult renal transplantation (RTx), ARE have been significantly reduced by mycophenolate mofetil (MMF) in combination with cyclosporin (CyA) and steroids (Pred). Reports of pediatric RTx on a maintenance immunosuppression with MMF are restricted to patients (P) after antibody induction therapy. METHODS: The efficacy and safety of MMF combined with CyA and Pred in pediatric RTx without induction therapy were evaluated in an open-labeled multicenter study. RESULTS: From 10/1996 to 6/1999, 65 pediatric P (MMF group) were followed for at least 6 months, 58 of 65 for 12 months. These P were compared with 54 retrospectively analyzed pediatric P who were transplanted between 1990 and 1996 and had received CyA, Pred, and azathioprine for immunosuppression (historic AZA group). Within the first 6 months after RTx, 18 of 65 (MMF group) and 32 of 54 (historic AZA group) P showed clinical signs of acute rejection (P<0.01). Thereafter only one further P in the MMF group developed a first ARE. Graft loss due to rejection occurred in one MMF- and seven AZA-treated P (P<0.05). The creatinine-clearance 3 and 6 months after RTx was higher in the MMF group. Major adverse events (MMF group) included infections of the urinary and the upper respiratory tract, diarrhea, and leukopenia. Cytomegalovirus-infection occurred in 13 P and 2 P developed cytomegalovirus disease. One P developed PTLD 10 months after RTx and recovered after the reduction of immunosuppression. CONCLUSIONS: The combination of MMF, CyA, and Pred reduced ARE in pediatric RTx without incurring major side effects.
Assuntos
Imunossupressores/uso terapêutico , Transplante de Rim , Ácido Micofenólico/análogos & derivados , Ácido Micofenólico/uso terapêutico , Adolescente , Criança , Ciclosporina/uso terapêutico , Quimioterapia Combinada , Feminino , Glucocorticoides/uso terapêutico , Rejeição de Enxerto/epidemiologia , Humanos , Imunossupressores/efeitos adversos , Incidência , Rim/fisiopatologia , Masculino , Ácido Micofenólico/efeitos adversos , Infecções Oportunistas/induzido quimicamente , Infecções Oportunistas/epidemiologia , Pacientes Desistentes do Tratamento , Prednisona/uso terapêutico , Estudos Prospectivos , Análise de Sobrevida , Resultado do TratamentoRESUMO
BACKGROUND: Pediatric allograft recipients are at an increased risk for lymphotropic virus-associated disorders, particularly in association with primary EBV infection. PATIENTS AND METHODS: Twenty-nine children, adolescents and young adults after renal transplantation were studied in comparison with a healthy young adult control group for evidence of primary, reactivated or chronic active EBV infection at two different time points. RESULTS: Prevalence of antibodies against viral capsid antigen (VCA) was > or = 90% in both groups, whereas anti-Epstein-Barr nuclear antigen (EBNA) was detected only in 19 of 26 seropositive patients compared with seropositive controls (p = 0.01). Persistence of EBV DNA in leukocytes for > or = 6 months was observed in 11 seropositive patients (38%) and one control patient (p < 0.007) using nested polymerase chain reaction. In the transplant recipients, 3 cases of primary EBV infection and 3 cases of chronic active EBV infection were identified. One of these cases developed a non-Hodgkin lymphoma one year later. CONCLUSION: The results suggest that determination of pretransplant antibody status in recipients, rapid detection of EBV infection in seronegative symptomatic recipients, and regular screening for persistent EBV DNA in patients at risk to develop post-transplantation lymphoproliferative disease should be performed.
Assuntos
Proteínas do Capsídeo , Herpesvirus Humano 4/isolamento & purificação , Transplante de Rim , Adolescente , Adulto , Anticorpos Antivirais/sangue , Antígenos Virais/imunologia , Capsídeo/imunologia , Criança , Pré-Escolar , Doença Crônica , DNA Viral/sangue , Infecções por Vírus Epstein-Barr/imunologia , Infecções por Vírus Epstein-Barr/virologia , Antígenos Nucleares do Vírus Epstein-Barr/imunologia , Feminino , Herpesvirus Humano 4/genética , Herpesvirus Humano 4/imunologia , Humanos , Transplante de Rim/imunologia , Masculino , Complicações Pós-Operatórias/imunologia , Complicações Pós-Operatórias/virologia , RecidivaRESUMO
BACKGROUND: Because of several studies, idiopathic nephrotic syndrome (INS) of childhood is suspected to have an immunologic pathogenesis with T cells playing a major role. To investigate this hypothesis further, we studied the diversity of the CDR3 region of the T-cell receptor (TCR) beta-chain from peripheral T cells isolated from patients with INS. METHODS: The study was performed over a three-year period to obtain longitudinal data on the repertoire of peripheral T cells. mRNA from peripheral mononuclear cells (PBMCs) of seven INS patients and two healthy controls (NHD) was prepared and analyzed for CDR3 length polymorphism of TCR beta-chain by spectratyping. RESULTS: All INS patients presented individually skewed spectratype histograms in at least one Vbeta-family. Patients suffering from a frequent relapsing course of INS or a focal global sclerosis showed some alterations to persist in all samples isolated in the observation period (up to 3 years). In addition, sequence analyses of the beta-chain of the TCR CDR3 region confirmed clonal expansion of peripheral T cells in those patients who had displayed spectratype alterations. CONCLUSIONS: The data give strong evidence for an direct involvement of CD8+ T cells in the complicated course of INS.
Assuntos
Linfócitos T CD8-Positivos/imunologia , Regiões Determinantes de Complementaridade , Genes Codificadores da Cadeia beta de Receptores de Linfócitos T/genética , Síndrome Nefrótica/imunologia , Idade de Início , Sequência de Aminoácidos , Linfócitos T CD4-Positivos/química , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD8-Positivos/química , Criança , Expressão Gênica/imunologia , Genes Codificadores da Cadeia beta de Receptores de Linfócitos T/imunologia , Humanos , Região Variável de Imunoglobulina/genética , Dados de Sequência Molecular , Síndrome Nefrótica/etiologia , Síndrome Nefrótica/fisiopatologia , Polimorfismo Genético , Receptores de Antígenos de Linfócitos T alfa-beta/química , Receptores de Antígenos de Linfócitos T alfa-beta/genética , Receptores de Antígenos de Linfócitos T alfa-beta/imunologia , Análise de Sequência de DNA , Subpopulações de Linfócitos T/imunologiaRESUMO
We present data on urinary oxalate (U(OX)), renal function, growth and bone age in a 10-year-old male with primary hyperoxaluria type 1. The patient had undergone combined liver-kidney transplantation at the age of 4.5 years. UOX increased up to 10(4) micromol/24 h after transplantation and declined to normal values thereafter. Excessive Uox concentrations after surgery might have been due to a bone pool of unsoluble oxalate and declined spontaneously. Creatinine clearance remained stable during observation period. The boy showed significant catch up growth. Height standard deviation score for chronological age improved from -2.4 before transplantation to -0.3 after 6 years. Radiological bone density improved at the same time. Hepatorenal transplantation should be performed in children with primary hyperoxaluria 1 before end-stage renal failure to normalize oxalate excretion and improve growth and bone mineralization.
Assuntos
Crescimento , Hiperoxalúria Primária/cirurgia , Transplante de Rim , Transplante de Fígado , Densidade Óssea , Criança , Pré-Escolar , Creatinina/metabolismo , Seguimentos , Taxa de Filtração Glomerular , Humanos , Hiperoxalúria Primária/fisiopatologia , Hiperoxalúria Primária/urina , Masculino , Oxalatos/urinaRESUMO
Metal ions or metal ions in complexes or compounds have been used for centuries to disinfect fluids, solids and tissues. The biocidal effect of silver, with its broad spectrum of activity including bacterial, fungal and viral agents, is particularly well known and the term "oligodynamic activity" was coined for this phenomenon. Silver ions have an affinity to sulfhydryl groups in enzyme systems of the cell wall, through which they interfere with the transmembranous energy transfer and electron transport of bacterial microorganisms. Silver ions also block the respiratory chain of microorganisms reversibly in low concentrations and irreversibly in higher concentrations. Binding to the DNA of bacteria and fungi increases the stability of the bacterial double helix and thus inhibits proliferation. There is no cross resistance with antibiotics and also no induction of antimicrobial resistance by silver ions. The concentrations required for bactericidal activity are in the range 10(-9) mol/l. These concentrations can be achieved in solution by the interaction of metallic silver with electrolytes only if there is a large enough surface of silver. By a novel technology, metallic silver is distributed in submicron particles in polyurethane and results in a concentration of 0.8% in an active surface of 450 cm2/g polyurethane. Polyurethane is hygroscopic and rapidly attracts water; the interaction of electrolyte solutions with the extremely finely distributed silver throughout the polyurethane releases bactericidal concentrations of silver ions over a period of years to the surface of the material. The electronegatively charged surface of bacteria attracts the positively charged silver ions. The concentrations released from the polyurethane are far below the toxic concentrations for humans.
Assuntos
Antibacterianos/farmacologia , Cateterismo Venoso Central/instrumentação , Controle de Infecções/métodos , Poliuretanos , Prata/farmacologia , Animais , Antibacterianos/toxicidade , Materiais Biocompatíveis , Cateterismo Venoso Central/efeitos adversos , Contaminação de Equipamentos/prevenção & controle , Humanos , Prata/toxicidadeRESUMO
To date there have been no standard methods for assessing the thrombogenicity of central venous catheters. A procedure for testing the thrombogenicity of intravenous lines such as the silver-impregnated catheter by continuous blood flow in vitro was therefore developed. For this test, fresh blood was drawn from healthy human donors and anti-coagulated with sodium citrate (1:9). All material tested (catheter tubes with and without silver manufactured in the same way, polyethylene tubes and tubes with potentially thrombogenic material) were perfused through their lumen with anticoagulated blood for up to 31 hours. Blood samples were collected at different times from the test system at sites before and after the perfusion of the test catheters. The hemoglobin concentration, erythrocyte, leukocyte and thrombocyte counts and markers for thrombin activation (thrombin-antithrombin III-complex, F1 + 2)-prothrombin fragments) and for hyperfibrinolysis (d-dimers) were determined. No thrombin activation or signs of hyperfibrinolysis were detected in any material tested. Polyethylene tubes were found to cause hemolysis, as shown by a decrease in hemoglobin content from 15 g% to 4.5 g%. Tecothane tubes with and without silver did not induce hemolysis.
Assuntos
Cateterismo Venoso Central/efeitos adversos , Trombose/etiologia , Antitrombina III/análise , Cateterismo Venoso Central/instrumentação , Hemoglobinas/análise , Humanos , Teste de Materiais/métodos , Protrombina/análise , Trombina/análiseRESUMO
The antimicrobial activity of a silver-impregnated polymer catheter (the Erlanger silver catheter) was demonstrated by determining the microbial adhesion to the surface of the catheter and by measuring the rate of proliferation (viability) of microorganisms at this site. On the surface of a catheter impregnated with silver, according to previously described methods, the bacterial adhesion of Staphylococcus epidermidis is reduced by 28-40%. Bacterial proliferation on the surface of the catheter and biofilm production are also substantially reduced by the elution of free silver ions from the catheter matrix. Bacteriostatic and bactericidal activities can be determined. The antimicrobial efficacy of the silver catheter is not reduced by blood components. There is no loss in antimicrobial activity for weeks after preincubation in water or phosphate buffered saline. The antimicrobial activity depends on the extent of the active silver surface.
Assuntos
Antibacterianos/farmacologia , Cateterismo/instrumentação , Contaminação de Equipamentos/prevenção & controle , Prata/farmacologia , Staphylococcus epidermidis/efeitos dos fármacos , Animais , Aderência Bacteriana/efeitos dos fármacos , Cateterismo/efeitos adversos , Humanos , Poliuretanos , Coelhos , Staphylococcus epidermidis/crescimento & desenvolvimentoRESUMO
The purpose of this investigation was to compare the local effects of polyurethane (Tecothane) and silicone tubes with or without silver impregnation in rats. Bacterial colonization or infection of the exit site and/or tunnel were documented and interpreted. All tubes were placed subcutaneously or percutaneously in the neck of 41 Sprague-Dawley rats and guided beneath the dorsal muscles into the peritoneal cavity. The incidence of bacterial abscesses along the implanted tubes was evaluated daily. After 90 days, or earlier if sepsis developed, the animals were killed painlessly and various organs and tissues from the entry site and the catheter tunnel examined histologically. In the group where polyurethane tubes were placed percutaneously, there was no difference in the frequency of abscesses between silver-impregnated and non-impregnated tubes (5/6 with and 5/7 without silver). The only difference noted was in the group with percutaneously placed silicone tubes between those with and without silver. Abscesses only occurred in 2/4 animals in the silver group and in 5/5 animals in the control group. Histological examination showed no difference in either group between infectious and foreign body reactions. Silver particles in subcutaneous, muscle and peritoneal tissue could not be demonstrated.
Assuntos
Cateterismo/instrumentação , Materiais Revestidos Biocompatíveis , Teste de Materiais/métodos , Compostos de Prata/imunologia , Animais , Materiais Biocompatíveis , Masculino , Poliuretanos , Ratos , Ratos Sprague-Dawley , Silício/imunologiaRESUMO
The Erlanger silver catheter consists of a new form of polyurethane, which contains finely dispersed metallic silver. The aim of this study was to establish the biocompatibility of this intravenous catheter by investigating the acute cytotoxicity of extracts from the Erlanger silver catheter on human fibroblasts and lymphocytes. Extracts of the Erlanger silver catheter were not cytotoxic for MRC-5 human fibroblasts nor for sensitized phytohemagglutinin (PHA)-stimulated human lymphocytes. The addition of silver powder of up to 2% by weight to the basic catheter polyurethane Tecothane led to no increase in acute cytotoxicity in comparison with untreated Tecothane. The Erlanger silver catheter is a new intravenous catheter with good biocompatibility.
Assuntos
Materiais Biocompatíveis , Cateterismo/efeitos adversos , Poliuretanos , Prata/toxicidade , Adulto , Cateterismo/instrumentação , Linhagem Celular , Fibroblastos/efeitos dos fármacos , Humanos , Linfócitos/efeitos dos fármacosRESUMO
It is difficult to make the clinical diagnosis of catheter-related infections using the available and established definitions of the HICPAC (Hospital Infection Control Practices Advisory Committee) of the CDC (Centers for Disease Control, definitions of nosocomial infections). The scoring system shown here is a modification of these definitions and has enabled the causal relationship between the catheter and clinical episodes of systemic infections to be quantitatively graded. The scoring system included the following criteria: height and rate of rise of body temperature, attendant shivering, identification of pathogens in blood and/or catheter tip cultures, improvement in the clinical course after catheter removal, signs of catheter exit site inflammation and results of diagnostic tests for other possible sources of infection. These criteria were graded using points and weighted according to their specificity. The comparative evaluation of 65 episodes of systemic infections using the scoring system and the diagnostic criteria of HICPAC showed agreement in 85%. No case was graded "false-negative." In nine of ten false-positive cases additional findings supported the presence of a catheter-associated infection. This scoring system appears, therefore, to be more sensitive than existing diagnostic criteria, without loss of specificity.
Assuntos
Cateterismo Venoso Central/efeitos adversos , Infecções/diagnóstico , Humanos , Infecções/fisiopatologia , Sepse/diagnóstico , Sepse/imunologia , Sepse/fisiopatologiaRESUMO
The clinical evaluation of venous catheters for catheter-induced infections must conform to a strict biometric methodology. The statistical planning of the study (target population, design, degree of blinding), data management (database design, definition of variables, coding), quality assurance (data inspection at several levels) and the biometric evaluation of the Erlanger silver catheter project are described. The three-step data flow included: 1) primary data from the hospital, 2) relational database, 3) files accessible for statistical evaluation. Two different statistical models were compared: analyzing the first catheter only of a patient in the analysis (independent data) and analyzing several catheters from the same patient (dependent data) by means of the generalized estimating equations (GEE) method. The main result of the study was based on the comparison of both statistical models.
Assuntos
Anti-Infecciosos/farmacologia , Infecções Bacterianas/prevenção & controle , Cateterismo Venoso Central/efeitos adversos , Prata/farmacologia , Infecções Bacterianas/etiologia , Cateterismo Venoso Central/instrumentação , Interpretação Estatística de Dados , Bases de Dados Factuais , Humanos , Controle de QualidadeRESUMO
A central venous catheter with a new form of silver impregnation of the internal and external surfaces was investigated for antimicrobial activity and tolerance in patients in a controlled comparative, prospective and randomized clinical study. Commercially available catheters with no antimicrobial activity were used as controls. One hundred sixty-five catheters were included in the final evaluation. All catheters were percutaneously inserted for the first time with a duration of > or = 5 days and a microbiological examination of the catheter tip. Catheter location (> 90% internal jugular vein), mean duration of catheterization (8-9 days), patients' age and diagnosis were comparable in both groups. Silver-impregnated catheter tips showed an incidence of colonization in 14.2/1000 catheter days and control catheters in 22.8/1000 catheter days. This represents a reduction of 37.7%. Catheter-associated infections were diagnosed in the silver group in 5.26/1000 catheter days and 18.34/1000 catheter days in the control group, indicating a reduction rate of 71.3% (P < 0.05, chi 2-test). No complications or side effects were documented in either group.
Assuntos
Infecções Bacterianas/prevenção & controle , Cateterismo Venoso Central/efeitos adversos , Contaminação de Equipamentos/prevenção & controle , Prata , Anti-Infecciosos/farmacologia , Infecções Bacterianas/epidemiologia , Infecções Bacterianas/etiologia , Cateterismo Venoso Central/instrumentação , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos ProspectivosRESUMO
Central venous long-term catheters offer reliable, large-lumen vascular access with high flow rates for delivery of nutrition or for cell-containing infusions and perfusions. Catheter-associated infections (CAI) pose the greatest threat to such vascular access, despite existing preventive measures. In this article one prospective and one retrospective study of CAI in pediatric therapy are presented. Study I: A retrospective investigation from 1990 through 1995 of 60 conventional long-term catheters in 50 patients. The total number of days in which the catheters were in place was 11,818. The calculated CAI incidence was 1 per 1,000 days of catheter insertion. Bacteriologically demonstrated CAI (identical isolate on the catheter tip and in a blood culture) occurred in three instances (5%). Five cases (8.3%) were diagnosed with a therapy-resistant, septic clinical picture. Study II: A prospective, randomized comparison of long-term silver-impregnated (Erlanger silver catheters) and control catheters (Quinton Instrument Co.) was made with 41 patients (20 with a silver catheter, 21 with a Quinton catheter). To date, the silver catheters have been distinguished by sterile bacteriological findings, whereas three cases of CAI have been demonstrated with the comparative catheters. One patient recently underwent intensive care after becoming unstable with signs of septic shock and demonstrable Pseudomonas aeruginosa, and two other patients manifested coagulase-negative staphylococci on the catheter tips. In three of nine control catheters an incidence of 1.18 per 1,000 days of indwelling catheters was found, whereas no CAI has occurred with the eight microbiologically tested silver catheters.
Assuntos
Anti-Infecciosos/farmacologia , Infecções Bacterianas/prevenção & controle , Cateterismo Venoso Central/efeitos adversos , Prata/farmacologia , Infecções Bacterianas/etiologia , Cateterismo Venoso Central/instrumentação , Criança , Pré-Escolar , Humanos , Estudos Prospectivos , Estudos Retrospectivos , Fatores de TempoRESUMO
Efficacy and pharmacokinetic parameters of imipenem/cilastatin (I/C) were investigated in a retrospective evaluation in 104 premature and newborn infants. Patients enrolled in this investigation constituted a particularly high risk group with extreme prematurity, perinatal asphyxia and amnion infection as well as various malformations. In 15 of the 104 infants serum concentrations were measured for drug monitoring and determination of optimal total daily dosage. A total daily dose of 50 mg/kg birth weight for premature and newborn infants divided into two doses led to imipenem peak concentrations of 17.7 mg/l +/- 9.2 mg/l (range: 1.95-38.05) and trough levels were 2.35 mg/l +/-1.02 (range 2.34-10.88) in premature infants. Imipenem peak concentrations of 20.6 +/- 10.8 (range 3.94-32.3) and trough levels of 0.43 +/- 0.17 (range 0.16-0.94) were measured in newborns. The half-life of elimination was 3.3 h and 1.86 h, respectively. Six of the 104 treated patients died, five of them of causes unrelated to infection. Seizures occurred in 8.9% of patients during therapy with I/C compared with 5.8% of a large survey of premature and newborn infants in our intensive care unit (ICU). However, the severity of illness of these two groups cannot be compared. I/C can be expected to constitute effective therapy in premature and newborn infants with serious nosocomial infections even after failure of other broad spectrum antibiotics.
Assuntos
Bacteriemia/tratamento farmacológico , Cilastatina/uso terapêutico , Imipenem/uso terapêutico , Doenças do Prematuro/tratamento farmacológico , Inibidores de Proteases/uso terapêutico , Tienamicinas/uso terapêutico , Bacteriemia/microbiologia , Bacteriemia/mortalidade , Cilastatina/farmacologia , Relação Dose-Resposta a Droga , Feminino , Humanos , Imipenem/farmacologia , Recém-Nascido , Doenças do Prematuro/mortalidade , Infusões Intravenosas , Unidades de Terapia Intensiva Neonatal , Masculino , Prognóstico , Inibidores de Proteases/farmacologia , Estudos Retrospectivos , Índice de Gravidade de Doença , Taxa de Sobrevida , Tienamicinas/farmacologiaRESUMO
Residual peritoneal volume may play an important role in dialysis efficacy and abdominal compliance in patients on chronic peritoneal dialysis (CPD). In children on CPD, the relationship between residual peritoneal volume and different measures of body size, as well as the day-to-day variability of residual volume, have not been established. We therefore investigated, on two consecutive days, residual peritoneal volume in 25 children on CPD, using the dextran dilution technique. Residual volume was linearly correlated with body size. Residual volume was independent of body size when normalized to body surface area, but decreased with increasing body size when normalized to body weight (r = -0.62, p < 0.001). Mean residual volume was 79 +/- 25 mL/m2, with an intra-individual day-to-day coefficient of variation of 21% +/- 15%. Residual volume was not correlated with the duration of PD, frequency of peritonitis, or peritoneal permeability as estimated by D/P creatinine or D/D0 glucose. In conclusion, residual peritoneal volume is constant across the pediatric age range when normalized to body surface area. It accounts for approximately 8% of the usual fill volume in patients on CPD. Residual volume is not a major confounder of the transport status estimation obtained by peritoneal equilibration test.
Assuntos
Superfície Corporal , Diálise Peritoneal , Peritônio/anatomia & histologia , Adolescente , Adulto , Criança , Pré-Escolar , Humanos , Lactente , Peritônio/fisiologiaAssuntos
Heterozigoto , Embolia e Trombose Intracraniana/terapia , Proteína C/genética , Proteína C/fisiologia , Veias Renais , Terapia Trombolítica/métodos , Trombose Venosa/terapia , Resistência a Medicamentos/genética , Humanos , Recém-Nascido , Injeções Intra-Arteriais , Embolia e Trombose Intracraniana/complicações , Masculino , Artéria Renal/diagnóstico por imagem , Ultrassonografia , Trombose Venosa/complicaçõesAssuntos
Autoanticorpos/imunologia , Síndrome de Down/complicações , Vasculite/complicações , Anticorpos Anticitoplasma de Neutrófilos , Anticorpos Antivirais/análise , Biomarcadores/sangue , Criança , Síndrome de Down/diagnóstico , Síndrome de Down/imunologia , Feminino , Glomerulonefrite/complicações , Glomerulonefrite/diagnóstico , Glomerulonefrite/imunologia , Infecções por Hantavirus/complicações , Infecções por Hantavirus/imunologia , Humanos , Vasculite/diagnóstico , Vasculite/imunologiaRESUMO
In modern medicine, infection is one of the most serious complications of implanted plastic devices. The host is not able to overcome this special type of opportunistic infection despite having a normal immune response and a low virulence of most of the bacteria involved. Antimicrobial therapy alone generally cannot cure the infection and the removal of catheters often remains the only choice of therapy. Bacterial adhesion to the polymer surface of the catheter, be it luminal or external, is an important step in the pathogenesis of catheter-associated infections. In this report, we describe new approaches to the prevention of infections by impregnation of polyurethane and silicone with silver by two different methods. The antimicrobial activity of these silver-impregnated catheters is more than 10 fold higher for coagulase-negative staphylococci (CNS) compared to catheters without silver. Similar results are obtained with other microbial organisms like Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa and Candida albicans. The new polymers show no cytotoxic or thrombogenic side effects in vitro.